Medial EarlySign vs Pomicell
Medial EarlySign vs Pomicell, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Medial EarlySign is on 49/100 and Pomicell on 46/100.
Where each one leads
Medial EarlySign
- our overall score: 49/100 against 46/100
- domain rating: 31/100 against 4/100
- headcount: 8 against 5
- funding raised: $50.0M against $300K
Pomicell
- LinkedIn following: 2,777 against 2,122
At a glance
| Measure | Medial EarlySign | Pomicell |
|---|---|---|
| What it is | Develops AI-powered decision support tools for personalized medical data interpretation and prediction. | Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights. |
| Category | Healthcare, Decision Support, Insights, Detection | Healthcare, Biotech, Decision Support, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2009 | 2016 |
| Headquarters | Tel Aviv, Israel | Jerusalem, Israel |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | Medial EarlySign | Pomicell |
|---|---|---|
| Employees | 8 | 5 |
| Headcount growthLast 12 months | -26.4% | -29.7% |
| Total funding | $50.0M | $300K |
| Latest round | Series B | Seed |
| LinkedIn followers | 2,122 | 2,777 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Medial EarlySign | Pomicell |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 46/100 |
| Traction | 48/100 | 35/100 |
| Team | 20/100 | 50/100 |
| Community | 15/100 | Not published |
| Search visibility | 29/100 | 36/100 |
| Quality | 58/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 31/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Medial EarlySign | Pomicell |
|---|---|---|
| CMS | Not detected | Wix |
Medial EarlySign vs Pomicell: common questions
Which is better, Medial EarlySign or Pomicell?
On our 0-100 score Medial EarlySign rates higher (49/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Medial EarlySign and Pomicell compare on the numbers?
Medial EarlySign leads on our overall score (49/100 against 46/100), domain rating (31/100 against 4/100), headcount (8 against 5), funding raised ($50.0M against $300K). Pomicell leads on LinkedIn following (2,777 against 2,122).
Read the full Medial EarlySign review and pricing or the Pomicell review and pricing. You can also browse other Medial EarlySign alternatives we track.